Braun J, Baraliakos X, Deodhar AA, et al. Secukinumab Demonstrates Low Radiographic Progression and Sustained Efficacy through 4 Years in Patients with Active Ankylosing Spondylitis. ACR 2017, abstract 3L.
Geen verband tussen gebruik biologicals en vroeggeboorte
mei 2018 | Arthritis psoriatica, Fibromyalgie, RA, SLE